CLINICAL_TRIALS
trial_result
· 2020-10-19
Clinical Trial Update: Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 trial updating the use of sorafenib with paclitaxel in metastatic breast cancer; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-10-19